7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue (Endostem)
Date du début: 1 janv. 2010, Date de fin: 31 déc. 2014,
We propose to develop new strategies to mobilize skeletal muscle tissue-associated stem cells as a tool for efficient tissue repair. This will be combined with exploring novel approaches that limit tissue damage, and will focus on agents that modify muscle and muscle vasculature progenitor cells. These molecules include nitric oxide associated with non-steroidal anti-inflammatory drugs, HMGB1, Cri ...
Voir le projet
22
Participants partenaires
TERMINÉ
A Coordinated and Structured International Post-Doctoral Program to Foster Trans-national Mobility and Independent Career of Scientists in Biomedicine (SIPOD)
Date du début: 16 mars 2009, Date de fin: 15 sept. 2014,
"This program encompasses the coordinated action of three major Biomedicine Research Centers and a Biotech shell in Lombardy, to launch a new Structured International Post-Doctoral program (SIPOD). These research centers operate in conjunction with the Scuola Europea di Medicina Molecolare (SEMM) whose aim is to promote the training and research of young scientists within emerging sectors of biome ...
Voir le projet
4
Participants partenaires
TERMINÉ
Optimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases (OptiStem)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2013,
This proposal aims to develop and implement efficacy of clinical trials with adult, tissue stem cells for degenerative diseases of epithelia and skeletal muscle. Extraordinary progress in the understanding of several key features of stem cells has been rapidly translated into novel cell therapy protocols that have yielded positive results in pre-clinical models of genetic and acquired diseases and ...
Voir le projet
20
Participants partenaires
TERMINÉ
European Stroke Research Network (EUSTROKE)
Date du début: 1 mars 2008, Date de fin: 31 août 2013,
The European Stroke Research Network (EUSTROKE) will be a collaborative effort that brings together researchers, government, industry, the non-profit sector and patient group associations. This network will put Europe at the forefront of stroke research through its multi-disciplinary research program, high-quality training for European scientists and clinicians, and national and global partnership ...
Voir le projet
17
Participants partenaires
TERMINÉ
Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering (AngioScaff)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2012,
Angiogenesis underlies almost all biological processes of morphogenesis, including those in tissue repair and regeneration. Physiological angiogenesis is controlled by a complex interplay between cells and their environment: the extracellular matrix (ECM) provides signaling via numerous ECM adhesion molecules and growth factors bound to ECM polysaccharide components; and cells locally degrade and ...
Voir le projet
33
Participants partenaires
TERMINÉ
Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer (GENINCA)
Date du début: 1 janv. 2008, Date de fin: 30 juin 2011,
"GENINCA will address two tumor entities, for which we have good access to pre-malignant lesions and in which genomic instability is a common feature: colorectal and liver cancer. Colorectal cancer amounts to 13.2% of all incident cases of cancer, the second most common form of cancer, surpassed only by lung cancer (13.3%). Liver cancer accounts for about 2% of total cancers, however, the most com ...
Voir le projet
14
Participants partenaires
TERMINÉ
Genomic Instability in Cancer and Precancer (GENICA)
Date du début: 1 janv. 2008, Date de fin: 31 déc. 2010,
"Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest that signs of genomic instability are evident from the very beginning of human cancer development, even in precancerous lesions. In these early lesions, the genomic instability affects primarily specific genomic loci, called common fragile sites. Because common ...
Voir le projet